Literature DB >> 2122729

Hypothalamic amenorrhea: clinical perspectives, pathophysiology, and management.

J H Liu1.   

Abstract

The development of functional hypothalamic amenorrhea reflects an individual's response to environmental stressors and life-style variables. In this disorder there are no detectable anatomic abnormalities with respect to the hypothalamic-pituitary-ovarian-endometrial axis. Current evidence suggests that the common underlying defect is a decrease in the activity of the hypothalamic gonadotropin-releasing hormone pulse generator. Of the neuroendocrine factors that appear to regulate gonadotropin-releasing hormone activity, the opiate and dopamine neuronal systems have been implicated as factors that are responsible in part for the decreased secretion of gonadotropin-releasing hormone. Because of the functional nature of this disorder, reactivation of the hypothalamic-pituitary unit would be expected to take place in most women after accommodation to environmental stressors or modification in life-style. For women with persistent anovulation, treatment with estrogen-replacement therapy should be offered. In those desiring fertility, ovulation induction with pulsatile gonadotropin-releasing hormone would be the most effective modality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122729     DOI: 10.1016/0002-9378(90)91437-h

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques.

Authors:  S M Herod; C R Pohl; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

2.  Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis.

Authors:  S M Herod; A M Dettmer; M A Novak; J S Meyer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

3.  Onset of natural menopause in African American women.

Authors:  Julie R Palmer; Lynn Rosenberg; Lauren A Wise; Nicholas J Horton; Lucile L Adams-Campbell
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

4.  Using an Ishikawa diagram as a tool to assist memory and retrieval of relevant medical cases from the medical literature.

Authors:  Kam Cheong Wong
Journal:  J Med Case Rep       Date:  2011-03-29

Review 5.  Premenopausal Reproductive Health Modulates Future Cardiovascular Risk - Comparative Evidence from Monkeys and Women.

Authors:  Jay R Kaplan; Stephen B Manuck
Journal:  Yale J Biol Med       Date:  2017-09-25

6.  Factors associated with menstrual cycle irregularity and menopause.

Authors:  Jinju Bae; Susan Park; Jin-Won Kwon
Journal:  BMC Womens Health       Date:  2018-02-06       Impact factor: 2.809

7.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13

Review 8.  Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link.

Authors:  Anindya Gupta; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2004-04-07       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.